Condition
Mediastinal Diseases
Total Trials
5
Recruiting
2
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed3
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05374447Not ApplicableCompleted
Diagnostic Yield of Intranodal Forceps Biopsies in Mediastinal Adenopathy
NCT06128681RecruitingPrimary
Diagnosis and Comprehensive Treatment of Mediastinal Interventional Technique
NCT06793579Completed
Lateral Approach for Mediastinal Lymph Node Dissection in Thyroid Cancer
NCT05694806RecruitingPrimary
Clinical Impact of Thoracic Scanographic Characteristics of Hematologic Malignancy Patients
NCT00373555Not ApplicableCompleted
Endobronchial Ultrasonography in the Diagnosis of Sarcoidosis
Showing all 5 trials